A top strategist suggests the market is settling down. Despite Covid-19 omicron risks, Oppenheimer Asset Management’s John Stoltzfus suggests Tuesday’s market bounce is real. “We believe...
PNC Financial is throwing cold water on the fourth-quarter rally. Covid omicron fears will take a heavy toll on risk appetites over the next two weeks,...
What to Know New York City is among the many cities worldwide grappling with an explosive surge of COVID-19 cases brought on by the Omicron variant...
The stock market’s volatility jump may be in its early stages. Despite a bullish 2022 outlook, Wilmington Trust’s Meghan Shue expects the wild swings to ramp...
The current flu vaccines appear to be a bad match for the dominant strain so far this influenza season, new research suggests, leading experts to warn...
U.S. officials intensified calls Friday for unvaccinated Americans to get inoculated in the face of the new omicron variant that contributed to a record number of...
Speaking to CNBC’s “Squawk Box,” President Joe Biden’s top medical advisor said that there was no doubt that optimum vaccination was with a booster dose. Currently,...
Investor Peter Boockvar is slamming the Federal Reserve over surging inflation that’s driving up the cost of essential, big-ticket items. As Fed policy makers gather for...
Invesco’s Kristina Hooper sees significant opportunities in regions shunned by a majority of investors. Despite the new omicron wave, she lists emerging markets — including China...
In a new study announced on Monday, researchers from the University of Oxford tested blood samples of people 28 days after their second dose of either...